COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-UpBehnood Bikdeli, Gregory Y.H. Lip, Alex C. Spyropoulos et al.|Journal of the American College of Cardiology|2020Cited by 2.9k
Dabigatran versus Warfarin in the Treatment of Acute Venous ThromboembolismSam Schulman, Samuel Z. Goldhaber, Clive Kearon et al.|New England Journal of Medicine|2009Cited by 2.6k
Moderate Alcohol Intake, Increased Levels of High-Density Lipoprotein and Its Subfractions, and Decreased Risk of Myocardial InfarctionJ. Michael Gaziano, Charles H. Hennekens, Julie E. Buring et al.|New England Journal of Medicine|1993Cited by 1k
Extended Use of Dabigatran, Warfarin, or Placebo in Venous ThromboembolismSam Schulman, Samuel Z. Goldhaber, Clive Kearon et al.|New England Journal of Medicine|2013Cited by 988
Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled AnalysisSam Schulman, Clive Kearon, Ajay K. Kakkar et al.|Circulation|2013Cited by 930